NeuBase Therapeutics, Inc. (NBSE)
NASDAQ: NBSE · IEX Real-Time Price · USD
0.450
+0.020 (4.58%)
At close: Mar 28, 2024, 3:57 PM
0.455
+0.005 (1.11%)
After-hours: Mar 28, 2024, 7:58 PM EDT

NeuBase Therapeutics Income Statement

Millions USD. Fiscal year is Oct - Sep.
Year 2022202120202019201820172016201520142013 2012 - 2004
Selling, General & Admin
11.8712.210.129.13.635.287.667.514.291.78
Upgrade
Research & Development
21.4514.366.9516.414.3217.4116.468.784.372.75
Upgrade
Other Operating Expenses
00007.181.171.191.520.470.09
Upgrade
Operating Expenses
33.3226.5717.0725.5115.1323.8525.3117.819.124.62
Upgrade
Operating Income
-33.32-26.57-17.07-25.51-15.13-23.85-25.31-17.81-9.12-4.62
Upgrade
Interest Expense / Income
0.020.030.010.13-0.070.03-0.010.010.010
Upgrade
Other Expense / Income
0.43-1.190.310.49-1.82-0.070.47-2.6101.03
Upgrade
Pretax Income
-33.78-25.41-17.38-26.13-13.24-23.81-25.77-15.2-9.13-5.65
Upgrade
Net Income
-33.78-25.41-17.38-26.13-13.24-23.81-25.77-15.2-9.13-5.65
Upgrade
Shares Outstanding (Basic)
2110000000
Upgrade
Shares Outstanding (Diluted)
2110000000
Upgrade
Shares Change
18.97%39.17%137.20%193.32%25.97%42.81%10.37%28.29%18.36%31.35%
Upgrade
EPS (Basic)
-20.80-18.60-17.80-63.20-92.00-212.00-328.00-216.00-164.00-120.00
Upgrade
EPS (Diluted)
-20.80-18.60-17.80-63.20-92.00-212.00-328.00-216.00-164.00-120.00
Upgrade
Free Cash Flow
-29.48-20.31-11.43-3.3-8.96-19.2-16-10.88-5.36-2.69
Upgrade
Free Cash Flow Per Share
-18.15-14.88-11.65-7.98-63.58-171.56-204.16-153.19-96.85-57.51
Upgrade
EBITDA
-32.49-24.8-17.1-25.87-12.19-22.62-24.59-14.01-8.66-5.56
Upgrade
Depreciation & Amortization
1.260.580.280.131.121.171.191.180.470.09
Upgrade
EBIT
-33.75-25.38-17.38-26-13.31-23.78-25.78-15.19-9.13-5.65
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).